Roivant Sciences (ROIV) Cash from Operations (2020 - 2025)
Roivant Sciences (ROIV) posted Cash from Operations of 586531000.0 for Q4 2025, down 215.91% on a QoQ basis from 185664000.0 in Q3 2025, and up 12.05% year-over-year from 523458044.28 in Q4 2024.
Roivant Sciences (ROIV) Cash from Operations (2020 - 2025) Analysis & Trends
Roivant Sciences' Cash from Operations history runs 6 years deep, the most recent figure standing at 586531000.0 for Q4 2025.
- Quarterly Cash from Operations rose 12.05% year-over-year to 586531000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1643464000.0 (up 7.84% YoY) and the FY2026 annual result came in at 750349000.0, up 10.61% from the prior year.
- Cash from Operations was 586531000.0 for Q4 2025 at Roivant Sciences, down from 185664000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 120596000.0 in Q3 2021 and bottomed at 666886000.0 in Q4 2024.
- A 5-year average of 340287466.67 and a median of 249932000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2021 — Cash from Operations tumbled 187.71% — and 2025, when it jumped 30.41%.
- Roivant Sciences' Cash from Operations stood at 530260000.0 in 2021, then retreated by 25.28% to 664305000.0 in 2022, then climbed by 1.13% to 656811000.0 in 2023, then retreated by 1.53% to 666886000.0 in 2024, then advanced by 12.05% to 586531000.0 in 2025.
- Business Quant data shows ROIV's Cash from Operations at 586531000.0 in Q4 2025, 185664000.0 in Q3 2025, and 204383000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -586.53 Mn |
| Dec 31, 2025 | -586.53 Mn |
| Sep 30, 2025 | -185.66 Mn |
| Sep 30, 2025 | -185.66 Mn |
| Jun 30, 2025 | -204.38 Mn |
| Jun 30, 2025 | -204.38 Mn |
| Dec 31, 2024 | -666.89 Mn |
| Dec 31, 2024 | -666.89 Mn |
| Sep 30, 2024 | -266.81 Mn |
| Sep 30, 2024 | -266.81 Mn |
| Jun 30, 2024 | -192.83 Mn |
| Jun 30, 2024 | -192.83 Mn |
| Dec 31, 2023 | -656.81 Mn |
| Dec 31, 2023 | -656.81 Mn |
| Sep 30, 2023 | -196.43 Mn |
| Sep 30, 2023 | -196.43 Mn |
| Jun 30, 2023 | -249.93 Mn |
| Jun 30, 2023 | -249.93 Mn |
| Dec 31, 2022 | -664.31 Mn |
| Dec 31, 2022 | -664.31 Mn |